Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate
Chengdu Easton Biopharmaceuticals Co Ltd cash flow reinvestment rate. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting CN¥24.30 Million (capex CN¥24.30 Million ) from operating cash flow of CN¥61.35 Million. See Chengdu Easton Biopharmaceuticals Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Cash flow reinvestment rate of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. Historical reinvestment intensity for Chengdu Easton Biopharmaceuticals Co Ltd across 13 annual periods. Explore Chengdu Easton Biopharmaceuticals Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate by Year (2013–2025)
Chengdu Easton Biopharmaceuticals Co Ltd cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Chengdu Easton Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see 688513 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CN¥105.96 Million | CN¥264.94 Million | CN¥86.28 Million | ▼ -11.5% |
| 2024 | 0.45x | CN¥118.92 Million | CN¥263.24 Million | CN¥117.42 Million | ▼ -78.8% |
| 2023 | 2.13x | CN¥585.44 Million | CN¥275.25 Million | CN¥175.26 Million | ▼ -56.6% |
| 2022 | 4.90x | CN¥745.03 Million | CN¥151.94 Million | CN¥339.33 Million | ▲ +97.3% |
| 2021 | 2.49x | CN¥366.88 Million | CN¥147.60 Million | CN¥256.29 Million | ▼ -59.3% |
| 2020 | 6.10x | CN¥955.44 Million | CN¥156.52 Million | CN¥198.81 Million | ▲ +372.0% |
| 2019 | 1.29x | CN¥183.40 Million | CN¥141.83 Million | CN¥95.41 Million | ▲ +181.4% |
| 2018 | 0.46x | CN¥76.63 Million | CN¥166.79 Million | CN¥76.63 Million | ▲ +71.0% |
| 2017 | 0.27x | CN¥23.02 Million | CN¥85.70 Million | CN¥23.02 Million | ▲ +59.8% |
| 2016 | 0.17x | CN¥17.83 Million | CN¥106.06 Million | CN¥17.83 Million | ▼ -76.0% |
| 2015 | 0.70x | CN¥35.43 Million | CN¥50.57 Million | CN¥35.43 Million | ▲ +48.5% |
| 2014 | 0.47x | CN¥22.04 Million | CN¥46.71 Million | CN¥22.04 Million | ▼ -82.6% |
| 2013 | 2.71x | CN¥76.11 Million | CN¥28.12 Million | CN¥76.11 Million | — |